HK1071704A1 - 有關生物活性物質 拖延分娩 的具有膠凝特性的組分 - Google Patents
有關生物活性物質 拖延分娩 的具有膠凝特性的組分Info
- Publication number
- HK1071704A1 HK1071704A1 HK05104957.8A HK05104957A HK1071704A1 HK 1071704 A1 HK1071704 A1 HK 1071704A1 HK 05104957 A HK05104957 A HK 05104957A HK 1071704 A1 HK1071704 A1 HK 1071704A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- composition
- bioactive substances
- gelling properties
- prolonged delivery
- prolonged
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0203059A FR2837099B1 (fr) | 2002-03-12 | 2002-03-12 | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
| US40572002P | 2002-08-26 | 2002-08-26 | |
| PCT/FR2003/000797 WO2003075885A1 (fr) | 2002-03-12 | 2003-03-12 | Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1071704A1 true HK1071704A1 (zh) | 2005-07-29 |
Family
ID=27806677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05104957.8A HK1071704A1 (zh) | 2002-03-12 | 2005-06-14 | 有關生物活性物質 拖延分娩 的具有膠凝特性的組分 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7691408B2 (zh) |
| EP (1) | EP1485066B1 (zh) |
| JP (1) | JP2005528352A (zh) |
| CN (1) | CN100584314C (zh) |
| AU (1) | AU2003227827B2 (zh) |
| BR (1) | BRPI0308360B8 (zh) |
| CA (1) | CA2478825C (zh) |
| HK (1) | HK1071704A1 (zh) |
| IL (1) | IL164031A (zh) |
| MX (1) | MXPA04008906A (zh) |
| NO (1) | NO339426B1 (zh) |
| NZ (1) | NZ535270A (zh) |
| WO (1) | WO2003075885A1 (zh) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ535270A (en) | 2002-03-12 | 2006-11-30 | Univ Montreal | Composition having gelling properties for the sustained delivery of bioactive substances |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| US8637070B2 (en) | 2005-02-09 | 2014-01-28 | Santen Pharmaceutical Co., Ltd. | Rapamycin formulations and methods of their use |
| US20070015689A1 (en) * | 2005-06-23 | 2007-01-18 | Alza Corporation | Complexation of metal ions with polypeptides |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| ATE553659T1 (de) * | 2006-07-24 | 2012-05-15 | Unilever Nv | Ausgangsstoff für ein getränk |
| BRPI0811319A2 (pt) | 2007-05-25 | 2015-02-10 | Tolmar Therapeutics Inc | Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento |
| FR2926996B1 (fr) * | 2008-01-31 | 2013-06-21 | Ethypharm Sa | Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine |
| US20110223208A1 (en) * | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| EP2425814B1 (en) * | 2010-09-03 | 2013-06-19 | Novagali Pharma S.A. | A water-in-oil type emulsion for treating a disease of the eye |
| AU2011298298B2 (en) * | 2010-09-03 | 2016-04-21 | Santen Sas | A water-in-oil type emulsion for treating a disease of the eye |
| US9107822B2 (en) | 2010-09-03 | 2015-08-18 | Santen Sas | Water-in oil type emulsion for treating a disease of the eye |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| JP6992057B2 (ja) | 2016-06-10 | 2022-01-13 | クラリティ コスメティックス インコーポレイテッド | 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法 |
| CN108479649A (zh) * | 2018-05-10 | 2018-09-04 | 哈尔滨工业大学 | 一种有机凝胶的制备方法与应用 |
| CN118201599A (zh) * | 2021-12-24 | 2024-06-14 | 四川科伦药物研究院有限公司 | 一种可平稳释放的持续性递送制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3932624A (en) | 1974-06-17 | 1976-01-13 | Morton-Norwich Products, Inc. | Method for prolonging the inhibitory effect of saralasin on angiotensin II |
| US3969087A (en) * | 1974-08-07 | 1976-07-13 | Ajinomoto Co., Ltd. | Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents |
| JPS5119139A (ja) * | 1974-08-07 | 1976-02-16 | Ajinomoto Kk | Gerujokeshoryososeibutsu |
| US5575815A (en) | 1988-08-24 | 1996-11-19 | Endoluminal Therapeutics, Inc. | Local polymeric gel therapy |
| SI9300468A (en) | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| JP3338057B2 (ja) * | 1993-10-18 | 2002-10-28 | ザ、プロクター、エンド、ギャンブル、カンパニー | 非発汗性口紅 |
| US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| US5702717A (en) | 1995-10-25 | 1997-12-30 | Macromed, Inc. | Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| US20010007673A1 (en) | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| BE1011899A6 (fr) | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
| US6306383B1 (en) | 1998-09-16 | 2001-10-23 | Wilson T Crandall | Method for topical treatment of scars with protein kinase C inhibitors |
| FR2794998B1 (fr) * | 1999-06-21 | 2001-07-27 | Oreal | Organogels et leurs utilisations notamment cosmetiques |
| FR2795360B1 (fr) | 1999-06-24 | 2001-12-14 | Technologique De Prec Mecaniqu | Procede de fabrication d'articles de conditionnement et machine de fabrication correspondante |
| NZ535270A (en) | 2002-03-12 | 2006-11-30 | Univ Montreal | Composition having gelling properties for the sustained delivery of bioactive substances |
-
2003
- 2003-03-12 NZ NZ535270A patent/NZ535270A/en not_active IP Right Cessation
- 2003-03-12 JP JP2003574161A patent/JP2005528352A/ja active Pending
- 2003-03-12 WO PCT/FR2003/000797 patent/WO2003075885A1/fr active Application Filing
- 2003-03-12 CA CA2478825A patent/CA2478825C/fr not_active Expired - Fee Related
- 2003-03-12 AU AU2003227827A patent/AU2003227827B2/en not_active Ceased
- 2003-03-12 EP EP03725281.4A patent/EP1485066B1/fr not_active Expired - Lifetime
- 2003-03-12 US US10/507,281 patent/US7691408B2/en active Active
- 2003-03-12 CN CN03810055A patent/CN100584314C/zh not_active Expired - Fee Related
- 2003-03-12 MX MXPA04008906A patent/MXPA04008906A/es active IP Right Grant
- 2003-03-12 BR BRPI0308360A patent/BRPI0308360B8/pt not_active IP Right Cessation
-
2004
- 2004-09-12 IL IL164031A patent/IL164031A/en not_active IP Right Cessation
- 2004-10-12 NO NO20044310A patent/NO339426B1/no not_active IP Right Cessation
-
2005
- 2005-06-14 HK HK05104957.8A patent/HK1071704A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04008906A (es) | 2005-09-08 |
| EP1485066B1 (fr) | 2016-09-21 |
| AU2003227827A1 (en) | 2003-09-22 |
| NO20044310L (no) | 2004-10-12 |
| EP1485066A1 (fr) | 2004-12-15 |
| US20060121115A1 (en) | 2006-06-08 |
| BRPI0308360B8 (pt) | 2021-05-25 |
| CN100584314C (zh) | 2010-01-27 |
| US7691408B2 (en) | 2010-04-06 |
| JP2005528352A (ja) | 2005-09-22 |
| NO339426B1 (no) | 2016-12-12 |
| WO2003075885A1 (fr) | 2003-09-18 |
| CN1649567A (zh) | 2005-08-03 |
| BR0308360B1 (pt) | 2017-11-14 |
| AU2003227827B2 (en) | 2008-09-25 |
| CA2478825A1 (fr) | 2003-09-18 |
| IL164031A (en) | 2010-11-30 |
| CA2478825C (fr) | 2012-01-24 |
| BR0308360A (pt) | 2005-01-25 |
| NZ535270A (en) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1071704A1 (zh) | 有關生物活性物質 拖延分娩 的具有膠凝特性的組分 | |
| AU2003222137A1 (en) | Microgel particles for the delivery of bioactive materials | |
| GB0310300D0 (en) | Nanocomposite drug delivery composition | |
| AU2003272654A1 (en) | Polymer compositions containing bioactive agents and methods for their use | |
| IL162183A0 (en) | Polymer-lipid delivery vehicles and methods for the preparation thereof | |
| AU2003291103A8 (en) | Pharmaceutical composition | |
| HK1183446A1 (zh) | 含有因子 的穩定藥物組合物 | |
| IL172814A0 (en) | Novel solid pharmaceutical composition comprising amisulpride | |
| EP1425019A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HK1076741A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| AU2003250372A8 (en) | Pharmaceutical composition | |
| SG118275A1 (en) | Polymers for the delivery of bioactive agents and methods of their preparation | |
| AU2003215706A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| AU2003272127A1 (en) | Polymeric composition for drug delivery | |
| AU2002308649A1 (en) | Compositions and methods for enhancing drug delivery | |
| HK1081451A1 (en) | Medicinal composition | |
| AU2003284460A1 (en) | Medicinal composition | |
| AU2003280799A1 (en) | Medicinal composition | |
| AU2003276498A8 (en) | Gelling composition | |
| IL164031A0 (en) | Composition having gelling properaties for the prolonged delivery of bioactive substances | |
| EP1696886A4 (en) | METHODS AND COMPOSITIONS FOR DELIVERY OF DRUGS | |
| GB0327814D0 (en) | Aerosolisable composition and delivery system | |
| HK1062274A1 (en) | Medicinal composition | |
| AU2003280678A1 (en) | Medicinal composition | |
| EP1547593A4 (en) | MEDICINAL COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210312 |